Status:
COMPLETED
A New Eye-based Communication Device for ALS Patients
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
National Research Agency, France
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Eighteen ALS patients will be trained to control a new communication device (Eye On Line: EOL) that permit over smooth eye movements to generate digits, letters, words or drawing at will. The interven...
Detailed Description
Background: Motor weakness progression in ALS challenges communication modalities such as writing or speech with a marked impairment of quality of life. In recent years the development of appropriate ...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- 18 to 65 years old
- patient with SLA diagnosis
- patient presenting writing troubles
- patient with understandable speaking communication
- patient with health insurance
- Exclusion criteria :
- patients presenting oculomotricity troubles
- patients presenting frontotemporal dementia
- patients presenting a chronic incapacitating disease other than ALS
- patients presenting epilepsy antecedents
- patents included in an other clinical study
Exclusion
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT02313402
Start Date
June 1 2014
End Date
April 1 2015
Last Update
November 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Pitie Salpetriere
Paris, France, 75013